SHISA9 and ependymoma: BST1, FLG, KANK4, and SHISA9 were significantly higher expressed in SP-EPN subtype A compared to all other ependymomas, whereas AK5, CFTR, RASSF6, and TBX22 showed high expression in subtype B.